Aminophenazone/Antipyrine/Barbital

氨基比林/安替比林/巴比妥

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAminophenazone/Antipyrine/Barbital
Drug Alias Name复方氨林巴比妥注射液
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitorsGamma-aminobutyric acid A receptor agonists
TargetsCyclooxygenase-2Gamma-aminobutyric acid A receptor
Therapy Area/IndicationsFever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsFever
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A